Therapeutic Innovations Against Opioid Tolerance and Addiction

• Published in: Current behavioral neuroscience reports 2024-09, Vol.11 (3), p.201-210
• Main Authors: Basaran, M. Berk, Koca, Raviye Ozen, Gormus, Z. Isik Solak
• Format: Article
• Language: English
• Subjects: Addictions; Analgesics; Behavioral Therapy; Desensitization (Psychology); Hyperalgesia; Kinases; Ligands; Medicine; Medicine & Public Health; Morphine; Narcotics; Nervous system; Neurology; Pain; Pediatrics; Physiology; Potassium; Proteins; Psychiatry; Spinal cord; Topical Collection on Addictions
• ISSN: 2196-2979; 2196-2979
• DOI: 10.1007/s40473-024-00277-8

Purpose of Review Opioids have a long history of use for relief of pain dating back thousands of years. Opium derived from the poppy plant is one of the earliest substances used for pain relief and continues to be employed as potent therapeutics for both acute and chronic pain. Despite the rapid and potent effects of opioids, their extensive negative side effect profile limits their clinical use. Some of the side effects associated with opioid use include constipation, nausea and vomiting, drowsiness and sedation, respiratory depression, itching, dizziness, and the development of opioid tolerance and dependence with prolonged use. Studies have revealed that the formation of dependence and tolerance involves not only a single intracellular signaling pathway but rather a complex communication network. While there is still an incomplete understanding of the mechanisms behind opioid tolerance and dependence, research has advanced our understanding, particularly focusing on the intracellular activation and regulation of opioid receptors. This article aims to unravel the complexities of opioid receptor function as we delve into the intricate network of intracellular signaling pathways and receptor regulation while offering insights into innovative methods that have emerged to address the potential side effects of opioid use. Recent Findings Opioids stimulate the release of dopamine primarily via the μ-opioid receptor (MOR) in the brain's reward pathway. This activation reinforces drug-seeking behavior and contributes to the development of addiction. In recent years, efforts have been made to intervene in the complex network of molecular-level opioid signaling, aiming to preserve the analgesic effects while reducing the serious side effects associated with opioid use. Some interventions focus on RGS proteins which play a crucial role in opioid signaling, while others explore the distinct effects created in intracellular G protein signaling using "biased" agonists. Another idea involves manipulating κ-opioid receptors (KORs) in the brain's reward pathway, which exhibit opposing effects to MORs. This approach aims not only to understand opioid addiction but also to shed light on conditions such as alcohol, drug, and food addiction. Summary This review article addresses molecular studies that have been focused on in recent years, especially against opioid dependence and other side effects, and it has raised the question of whether the side effects of opioids can be